This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
NEW YORK, Dec. 13, 2013 /PRNewswire/ -- Morgan & Morgan announces that it is investigating possible claims against the Board of Directors of Chemed Corporation ("Chemed") (NYSE: CHE) relating to alleged violations of the False Claims Act.
The United States Department of Justice (DOJ) filed a lawsuit in May of 2013 against Chemed and its affiliates alleging that Chemed defrauded Medicare by knowingly submitting false Medicare claims for hospice services that were either unnecessary, were not provided, or were provided to ineligible patients. Our investigation seeks to determine if the Chemed Board of Directors breached their fiduciary duties to shareholders in connection with the alleged violations cited by the DOJ.
If you own shares of Chemed and would like more information about the Chemed investigation, please contact
George Pressly, Esq. at 1(800) 631-6234 or email George at
Morgan & Morgan is one of the nation's largest 200 law firms. In addition to
securities fraud, the firm also practices in the areas of antitrust, personal injury, consumer protection, overtime, and product liability. All of the Firm's legal endeavors are rooted in its core mission: provide investor and consumer protection and always fight "for the people."
Attorney advertising. Prior results do not guarantee a similar outcome.
Contact:Morgan & Morgan
Peter Safirstein, Esq.28 West 44th StreetSuite 2001
New York, NY 100361-800-631-6234
SOURCE Morgan & Morgan